This agent has been shown to decrease lung inflammation and improve lung function in CF patients by potentially restoring autophagy and allowing CFTR to be trafficked to the cell membrane in a recent clinical trial [17, 69]. The gene discussed is CFTR; the disease is cystic fibrosis.